192 related articles for article (PubMed ID: 34046345)
1. Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study.
Guan T; Qiu Z; Su M; Yang J; Tang Y; Jiang Y; Yao D; Lai Y; Li Y; Liu C
Front Oncol; 2021; 11():641955. PubMed ID: 34046345
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Outcomes in the Patients With Primary Central Nervous System Lymphoma: A Multi-Registry Based Cohort Study of 4,038 Cases.
Qiu Z; Tang Y; Jiang Y; Su M; Wang X; Xu X; Chen Y
Front Oncol; 2021; 11():691038. PubMed ID: 34290986
[TBL] [Abstract][Full Text] [Related]
3. Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study.
Chi K; Zhou R; Luo Z; Zhao H; Jiang Y; He B; Li Y; Chen D; Feng M; Liang Y; Yang W; Liu R; Yao D; Lin X; Xu X
Front Oncol; 2023; 13():1096027. PubMed ID: 36845683
[TBL] [Abstract][Full Text] [Related]
4. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
5. The role of additional radiotherapy for primary central nervous system lymphoma.
Zacher J; Kasenda B; Engert A; Skoetz N
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009211. PubMed ID: 24931518
[TBL] [Abstract][Full Text] [Related]
6. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Bergner N; Monsef I; Illerhaus G; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Nov; 11():CD009355. PubMed ID: 23152274
[TBL] [Abstract][Full Text] [Related]
7. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
8. Risk of cardiac-related death in astrocytoma patients treated with chemotherapy: A competing risk analysis using the SEER database.
Wang X; Li X; Wu Y; Hong J; Chai D; Zhang M
Front Cardiovasc Med; 2023; 10():996354. PubMed ID: 37180801
[TBL] [Abstract][Full Text] [Related]
9. Resection of primary central nervous system lymphoma: impact of patient selection on overall survival.
Schellekes N; Barbotti A; Abramov Y; Sitt R; Di Meco F; Ram Z; Grossman R
J Neurosurg; 2021 Feb; 135(4):1016-1025. PubMed ID: 33636699
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
Uldrick TS; Pipkin S; Scheer S; Hessol NA
AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
12. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
13. Increased Risk of Cardiovascular Death in Breast Cancer Patients Without Chemotherapy or (and) Radiotherapy: A Large Population-Based Study.
Guan T; Zhang H; Yang J; Lin W; Wang K; Su M; Peng W; Li Y; Lai Y; Liu C
Front Oncol; 2020; 10():619622. PubMed ID: 33585246
[TBL] [Abstract][Full Text] [Related]
14. Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma.
Lin CH; Yang CF; Yang HC; Fay LY; Yeh CM; Kuan AS; Wang HY; Gau JP; Hsiao LT; Chiou TJ; Chen PM; Liu YC; Ko PS; Liu JH; Liu CJ
J Cancer; 2019; 10(17):3958-3966. PubMed ID: 31417640
[No Abstract] [Full Text] [Related]
15. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma in the United States, 1975-2017.
Lv C; Wang J; Zhou M; Xu JY; Chen B; Wan Y
Ther Adv Hematol; 2022; 13():20406207211066166. PubMed ID: 35096360
[TBL] [Abstract][Full Text] [Related]
18. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
Kasenda B; Ferreri AJ; Marturano E; Forst D; Bromberg J; Ghesquieres H; Ferlay C; Blay JY; Hoang-Xuan K; Pulczynski EJ; Fosså A; Okoshi Y; Chiba S; Fritsch K; Omuro A; O'Neill BP; Bairey O; Schandelmaier S; Gloy V; Bhatnagar N; Haug S; Rahner S; Batchelor TT; Illerhaus G; Briel M
Ann Oncol; 2015 Jul; 26(7):1305-13. PubMed ID: 25701456
[TBL] [Abstract][Full Text] [Related]
19. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
[TBL] [Abstract][Full Text] [Related]
20. Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
Schorb E; Finke J; Ihorst G; Kasenda B; Fricker H; Illerhaus G
BMC Cancer; 2019 Mar; 19(1):287. PubMed ID: 30925912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
